Featured Articles

The Role of Medications in the Empl...

Over the past half-century, many different vocational rehabilitation strategies have been used to help mental health ...

Complete Information on Erythema el...

Erythema elevatum diutinum is a chronic and uncommon dermatosis that is considered to be a variation of leukocytoclas...

Roseola Disease - The Facts

Roseola is a viral illness in young children, most commonly affecting those between the ages of 6 months and 2 years. ...

A Few Adhd Treatment Options Before...

There are several alternative treatment options available to the parents of children correctly diagnosed with ADHD or A...

The Global Diabetes Market was Wort...

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c37670) has announced the addition...

FIND A DRUG

Pharmacy Locator

ZIP Distance

Use this tool to find
pharmacies in your area

Drug Information Related to Pamidronate Disodium

Back

01. Pamidronate Disodium Therapy for Improved Patient Outcome Presented at...

SEATTLE--(BUSINESS WIRE)--Dec. 4, 1995--Today at the American Society of Hematology's (ASH) 37th Annual Meeting & Exposition researchers from UCLA School of Medicine presented results from a 21-month, Phase III clinical study showing that "Long-term Pamidronate p...

02. Bisphosphonate-associated scleritis: a case report and review. - Free ...

Abstract: An 86-year-old female was treated for osteoporosis with alendronate, an aminobisphosphonate. Six weeks after alendronate therapy began, scleritis developed in the patient's right eye. The alendronate was discontinued, and, with the administration of pr...

03. Mayne Pharma (USA), Paramus, NJ, Feb. 1, (New Jersey). - Free Online ....

From Sept. 13-Oct. 6, 2004, FDA Investigator Tara Gooen said Mayne failed to submit Adverse Drug Experience (ADE) reports to FDA. The following are examples of ADEs or information regarding ADEs that were not submitted to FDA, according to the warning letter:: ...

04. Hudson Technologies counters newspaper report on culpability in aquife...

HILLBURN, N.Y.--(BUSINESS WIRE)--Dec. 4, 1995--Hudson Technologies Inc. (NASDAQ:HDSN), the nation's largest reclaimer, purifier and recycler of commercial refrigerants, said Monday that, contrary to a recent local newspaper report, the company has been informe...

05. ADAC HealthCare Information Systems Makes Key Appointment. - Free ......

MILPITAS, Calif.--(HealthWire)--Dec. 4, 1995--ADAC ADAC - Aboriginal Drug and Alcohol CouncilADAC - Accelerated Durability Assessment ConfigurationADAC - Acoustic Data Analysis Center (US Army)ADAC - Alabama Disabilities Action CoalitionADAC - Alcohol and Drug Abuse ...

06. Aredia is cleared for marketing by FDA for use in Multiple Myeloma ......

EMERYVILLE, Calif.--(HealthWire)--Sept. 5, 1995--Chiron Corporation (NASDAQ:CHIR) and Ciba Pharmaceuticals jointly announced today that the United States Food and Drug Administration (FDA) has cleared for marketing Aredia (pamidronate disodium for injection) as the firs...

07. Q A | Health News | Find Articles at BNET

Q I'm taking bisphosphonates for my osteoporosis, but I've heard it can cause a serious jaw condition. Is this something I should be concerned about? ...

08. Osteogenesis imperfecta: Results of intravenous pamidronate treatment ...

Introduction and purpose: Osteogenesis imperfecta is a congenital disorder of the connective tissue, osteoporosis being the main complication with multiple fractures, Different therapy models have been tried in order to decrease bone resorption. Bisphosphanates are a gr...

09. Bisphosphonates | Encyclopedia of Cancer | Find Articles at BNET

Definition ...

10. Novartis Submits NDA For Zometa(r) (zoledronic acid for injection ......

Novartis Pharmaceuticals Corporation today announced that it has submitted a new drug application (NDA) to the U.S. Food and Drug Administration for Zometa(TM) (zoledronic acid for injection) for the treatment of tumor-induced hypercalcemia (TIH). A potentially life-thr...

11. Long-term bisphosphonate use may damage jaw | OB/GYN News | Find ......

Prolonged use of bisphosphonate therapy can lead to osteonecrosis of the jaw--a previously unrecognized and potentially serious complication that can often be avoided, according to Salvatore Ruggiero, M.D. ...

12. Ask Dr. Leipzig | Focus on Healthy Aging | Find Articles at BNET

I've seen a number of ads saying that I should "cleanse" my insides. Is this necessary? The idea behind detoxification diets is that chemicals, pollutants, and other toxins from the environment build up in your body over time. By sticking to a diet of only j...

13. FDA Advisory Committee Recommends Approval Of Novartis Drug ZOMETA(R ....

Novartis announced today that the Oncologic Drugs Advisory Committee (ODAC) of the U.S. Food and Drug Administration (FDA) recommended approval of ZOMETA(R) (zoledronic acid for injection) for the treatment of bone complications (metastases) associated with a broad rang...